Home • Projects • Erbitux (Cetuximab) - Investigational Biological

Over expression of EGFR correlates with increased metastasis, decreased survival and a poor prognosis. (Source: ABPI)

«Back	|	Next»

---

Home | New On This Site | Products & Services | Company A-Z | Industry Projects | White Papers | Jobs & Careers | Press Releases | Events & Exhibitions | Newsletter | Organisations | About Us | Contact Us | Advertise With Us |